Methotrexate dosing regimen for plaque-type psoriasis: an update of a systematic review
Background Methotrexate (MTX) is a systemic treatment for plaque-type psoriasis. At the time of approval, no dose-ranging studies were performed. Nowadays, a uniform dosing regimen is lacking. This might contribute to suboptimal treatment with the drug. Objective To summarize the literature involvin...
Main Authors: | Astrid M. van Huizen, Rosie Sikkel, Anouk G.M. Caron, Stef P. Menting, Phyllis I. Spuls |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-11-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2022.2117539 |
Similar Items
-
The wide variety of methotrexate dosing regimens for the treatment of atopic dermatitis: a systematic review
by: Anouk G. M. Caron, et al.
Published: (2024-12-01) -
A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
by: Divyanshu Srivastava, et al.
Published: (2023-01-01) -
Ulcerations in chronic plaque psoriasis: A diagnostic clue for acute methotrexate toxicity
by: Anitha Bhakthavatsalam, et al.
Published: (2023-01-01) -
The Effect of Methotrexate 1% Topical Gel on Psoriasis
by: Gita Faghihi, et al.
Published: (2012-03-01) -
Side Effects of Methotrexate for Psoriasis Therapy
by: Melida Agustina, et al.
Published: (2020-07-01)